PALLIATIVE RADIATION DURING PEMETREXED PLUS CISPLATIN FIRST-LINE TREATMENT OR PEMETREXED CONTINUATION MAINTENANCE TREATMENT IN ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A REPORT OF PATIENT SAFETY IN THE PARAMOUNT TRIAL

被引：0
|
作者：
De Marinis, Filippo [1 ]
Gridelli, Cesare [2 ]
Dediu, Mircea [3 ]
Thomas, Michael [4 ]
Pujol, Jean-Lois [5 ]
Molinier, Olivier [6 ]
Reck, Martin [7 ]
Sahoo, Tarini P. [8 ]
San Antonio, Belen [9 ]
John, William J. [10 ]
Zimmermann, Annamaria H. [10 ]
Chouaki, Nadia [11 ]
Visseren-Grul, Carla [12 ]
Paz-Arez, Luis G. [13 ]
机构：
[1] Azienda Osped San Camillo Forlanini, Rome, Italy
[2] SG Moscati Hosp, Avellino, Italy
[3] Inst Oncol, Bucharest, Romania
[4] Univ Klinikum Heidelberg, Thoraxklin, Heidelberg, Germany
[5] Montpellier Acad Hosp, Montpellier, France
[6] Le Mans Reg Hosp, Le Mans, France
[7] Krankenhaus Grosshansdorf, Zentrum Pneumol & Thoraxchirurg, Grosshansdorf, Germany
[8] Jawaharlal Nehru Canc Hosp & Res Ctr, Bhopal, Madhya Pradesh, India
[9] Eli Lilly & Co, Madrid, Spain
[10] Eli Lilly & Co, Indianapolis, IN USA
[11] Eli Lilly & Co, Paris, France
[12] Eli Lilly & Co, Med Oncol, Amsterdam, Netherlands
[13] Univ Hosp, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
radiotherapy; patient safety; non-small cell lung cancer; nonsquamous;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.08-019
引用
收藏
页码：S842 / S843
页数：2
相关论文
共 50 条
  • [31] First-line carboplatin, pemetrexed, and panitumumab in patients with advanced nonsquamous KRAS wild type (WT) non-small cell lung cancer (NSCLC)
    Mekhail, Tarek
    Waterhouse, David Michael
    Hadley, Terence J.
    Webb, Charles D.
    Burris, Howard A.
    Hainsworth, John D.
    Greco, F. Anthony
    Spigel, David R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT
    Yang, James Chin-Hsin
    Ahn, Myung-Ju
    Nakagawa, Kazuhiko
    Tamura, Tomohide
    Barraclough, Helen
    Enatsu, Sotaro
    Cheng, Rebecca
    Orlando, Mauro
    [J]. CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 424 - 435
  • [33] Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study
    Santoro, Armando
    Hillerdal, Gunnar N.
    Hoeffkenc, Gert
    Favaretto, Adolfo
    Carrion, Ramon Perez
    Visseren-Grul, Carla
    Ameryckx, Sophie
    Helsberg, Karin
    Soldatenkova, Victoria
    Bourayou, Nawel
    Sorensen, Jens B.
    [J]. LUNG CANCER, 2014, 86 (01) : 47 - 53
  • [34] Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial
    Gervais, Radj
    Robinet, Gilles
    Clement-Duchene, Christelle
    Denis, Fabrice
    El Kouri, Claude
    Martin, Philippe
    Chouaki, Nadia
    Bourayou, Nawel
    Morere, Jean-Francois
    [J]. LUNG CANCER, 2013, 80 (02) : 185 - 190
  • [35] Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer
    Patel, Jyoti D.
    Hensing, Thomas A.
    Rademaker, Alfred
    Hart, Eric M.
    Blum, Matthew G.
    Milton, Daniel T.
    Bonomi, Philip D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3284 - 3289
  • [36] Comparison of pemetrexed plus cisplatin versus pemetrexed plus carboplatin in the initial treatment of locally advanced or metastatic non-small cell lung cancer
    Pereira, A. A. R.
    Lessa, R. C.
    Souza, C. E. P.
    Pinto, F. A. I.
    Gagliato, D. M.
    Santos, E. S.
    Fanelli, M. F.
    Rinck, J. A.
    Dettino, A. A.
    Nicolau, U. R.
    Chinen, L. T. D.
    de Lima, V. C. C.
    Pereira, J. R.
    Cruz, M. R. D. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Safety, Resource Use, and Quality of Life in PARAMOUNT A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Gridelli, Cesare
    de Marinis, Filippo
    Pujol, Jean-Louis
    Reck, Martin
    Ramlau, Rodryg
    Parente, Barbara
    Pieters, Thierry
    Middleton, Gary
    Corral, Jesus
    Winfree, Katherine
    Melemed, Symantha
    Zimmermann, Anna
    John, William
    Beyrer, Julie
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz-Ares, Luis G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : 1713 - 1721
  • [38] Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC).
    Alshehri, Abdulrahman Ali
    Alsubait, Saud Abdullrhman
    Alamgir, M. Ahsan
    Park, Chandler
    Wen, Sijin
    Luo, Jin
    Ma, Patrick
    Monga, Manish
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Paz-Ares, Luis G.
    de Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Olivier
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Corral, Jesus
    Melemed, Symantha
    John, William
    Chouaki, Nadia
    Zimmermann, Annamaria H.
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) : 2895 - +
  • [40] EFFICIENCY OF CISPLATIN, PEMETREXED, AND BEVACIZUMAB AS FIRST-LINE TREATMENT FOR JAPANESE ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS
    Shiraishi, Yoshimasa
    Hirai, Humihiko
    Yamaguchi, Masafumi
    Morodomi, Yosuke
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Takenaka, Tomoyoshi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
12345